period last year. rising exports, helped by tourism, should help it lower the deficit this year. greece outlined a financial stability plan to the european union in april. price rises seem to be coming under control in sri lanka as consumer price inflation fell by half between may and june. back in september inflation peaked at 67% year on year, but is now running atjust under 11%. asia 5 most advanced economy is no longer an outlier in inflation. injapan, the pace of price rises is still increasing. japan s core inflation forjune came in at 3.3% just up from 3.2% in may numbers that many economies may be somewhat jealous of!
interest, that in all of our interest, that in all of our interest that we don t see this long immature scarring on young people because of what happened during covid. long term scarring. some warning lights flashing alpha west minister. i think politicians and all parties really need to ask tough questions about how to close those gaps. t questions about how to close those a s. ~ questions about how to close those i a . 5, ~ , questions about how to close those i a 5, ~ , , ., ., gaps. i think this will resonate with a lot gaps. i think this will resonate with a lot of gaps. i think this will resonate with a lot of parents. - gaps. i think this will resonate with a lot of parents. i - gaps. i think this will resonate with a lot of parents. i don t . gaps. i think this will resonate i with a lot of parents. i don t know what it s like in the united states but a lot of parents i talk to talk about the resilience of young people. and also how they have lost out with their educa
In the recently published PatientView report, Gilead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally Gilead also ranks first among peers in Asia by patient groups in this region HONG KONG, Sept. 15, 2022 /PRNewswire/ Gilead Sciences, Inc. ranks first among peers for overall corporate reputation, according to 300 Asian patient groups and 111 hepatitis patient groups in the 2021 PatientView Corporate Reputation of Pharma survey. This recognition is testament to Gilead's strong focus on patient centricity and deep commitment to working with patient groups to enhance the quality of care for communities across the world. "This is a remarkable achievement for Gilead and it is heartening to know that patient groups rate us highly in all areas - seeing us as the partner of choice," said Dustin Haines, Vice President & General Manager, Asia 5, Gilead Sciences. "We put patients at the heart of everything we do, and